Infraserv GmbH & Co. Hoechst KG
Infraserv GmbH & Co. Hoechst KG is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial with extension period to evaluate the efficacy and safety of Xeomin® injections for the prevention of chronic migraine
Sponsor Merz Therapeutics GmbH
- Start (EU)
- Latest update
- Estimated end
A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial with extension period to evaluate the efficacy and safety of Xeomin® injections for the prevention of episodic migraine
Sponsor Merz Therapeutics GmbH
- Start (EU)
- Latest update
- Estimated end
Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity caused by stroke or traumatic brain injury in adult subjects, followed by an open label extension with or without combined upper limb treatment
Sponsor Merz Pharmaceuticals GmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Infraserv GmbH & Co. Hoechst KG?
The 2026-10-09 snapshot links Infraserv GmbH & Co. Hoechst KG to 3 distinct CTIS trials. Recorded services include 24 hours emergency unblinding service and hotline, 24 hours emergency unblinding service. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Infraserv GmbH & Co. Hoechst KG?
The most frequently recorded therapeutic areas are Neurology, Pain Medicine. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Infraserv GmbH & Co. Hoechst KG conducted?
The linked trials record locations in 11 countries, including Czechia, Germany, Spain, France, Italy. These are trial locations, not confirmed office locations or countries where Infraserv GmbH & Co. Hoechst KG delivered services.
What can this page tell me about Infraserv GmbH & Co. Hoechst KG's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Infraserv GmbH & Co. Hoechst KG. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Infraserv GmbH & Co. Hoechst KG